Cell wall components of Staphylococcus aureus induce interleukin-5 production in patients with atopic dermatitis

Journal of Interferon and Cytokine Research

Volumn 20, Issue 3, 2000, Pages 321-324

  Matsui, Katsuhiko ^a   Motohashi, Ryo ^a   Nishikawa, Akemi ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; LIPOTEICHOIC ACID; PEPTIDOGLYCAN;

ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOPATHOLOGY; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ADJUVANTS, IMMUNOLOGIC; ADULT; CELL WALL; CELLS, CULTURED; DERMATITIS, ATOPIC; HUMANS; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; LYMPHOCYTES; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 0034073850     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312469     Document Type: Article

References (19)

1. 1. LEUNG, D.Y. (1995). Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J. Allergy Clin. Immunol. 96, 302-318.
2. 2. LEYDEN, J.J., MARPLES, R.R., and KLINGMAN, A.M. (1974). Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-529.
3. 3. HANIFIN, J.M., and HOMBURGER, H.A. (1986). Staphylococcal colonization, infection, and atopic dermatitis: association not etiology. J. Allergy Clin. Immunol. 78, 563-566.
4. 4. GLOOR, M., PETERS, G., and STOIKA, D. (1992). On the resident aerobic bacterial skin flora in unaffected skin of patients with atopic dermatitis and in normal controls. Dermatologia 164, 258-265.
5. 5. LEUNG, D.Y.M., TRAVERS, J.B., and NORRIS, D.A. (1995). The role of superantigens in skin disease. J. Invest. Dermatol. 105(Suppl. 1), 37-42.
6. 6. NEUBER, K., STEINRÜCKE, K., and RING, J. (1995). Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-γ, interleukin-4 and interleukin-5 production in atopic eczema. Int. Arch. Allergy Immunol. 107, 179-182.
7. 7. KÖNIG, B., NEUBER, K., and KÖNIG, W. (1995). Responsiveness of peripheral blood mononuclear cells from normal and atopic donors to microbial superantigens. Int. Arch. Allergy Immunol. 106, 124-133.
8. 8. NEUBER, K., and KÖNIG, W. (1992). Effects of Staphylococcus aureus cell wall products (teichoic acid, peptidoglycan) and enterotoxin B on immunoglobulin (IgE, IgA, IgG) synthesis and CD23 expression in patients with atopic dermatitis. Immunology 75, 23-28.
9. 9. GILLISSEN, G., and PUSZTAIA, M.S. (1987). Möglichkeiten einer ätiologischen oder modulatorischen Bedeutung von mikrobiellen Infektionen bei Allergien vom Soforttyp. Allergologie 10, 437-446.
10. 10. LAMBERT, P.A., HANCOCK, I.C., and BADDILEY, J. (1977). Occurrence and function of membrane teichoic acids. Biochim. Biophys. Acta 472, 1-12.
11. 11. FISCHER, W. (1989). Bacterial phosphoglycolipids and lipoteichoic acids. In: Handbook of Lipid Research. D.J. Hannah (eds) New York: Plenum, pp. 123-234.
12. 12. PARK, J.T., and HANCOCK, R. (1960). A fractionation procedure for studies of the synthesis of cell-wall mucopeptide and other polymers in cells of Staphylococcus aureus. J. Gen. Microbiol. 22, 249-258.
13. 13. HUGHES, R.C. (1965). The isolation of structural components present in the cell wall of Bacillus licheniformis N.C.T.C. 6346. Biochem. J. 96, 700-709.
14. + T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK 506 and cyclosporin A. Int. Immunol. 7, 449-457.
15. 15. WOOLF, C.M. (1968). Test of significance. In: Principles of Biometry. Princeton, NJ: Van Nostrand Company, pp. 42-61.
16. 16. JAPPE, U., HEUCK, D., WITTE, W., and GOLLNICK, H. (1998). Superantigen production by Staphylococcus aureus in atopic dermatitis: no more than a coincidence? J. Invest. Dermatol. 110, 844-846.
17. 17. MORI, A., SUKO, M., NISHIZAKI, Y., KAMINUMA, O., MATSUZAKI, G., ITO, K., ETOH, T., NAKAGAWA, H., TSURUOKA, N., and OKUDAIRA, H. (1994). Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int. Arch. Allergy Immunol. 104(Suppl. 1), 32-35.
18. 18. HAMID, Q., BOGUNIEWICZ, M., and LEUNG, D.Y.M. (1994). Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94, 870-876.
19. 19. IMOKAWA, G., ABE, A., JIN, K., HIGAKI, Y., KAWASHIMA, M., and HIDANO, A. (1991). Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96, 523-526.